Explore how genetic mutations and epigenetic changes work together to drive the development of leukemia, featuring key research and experimental data.
Exploring how next-generation sequencing technology is transforming minimal residual disease detection in pediatric B-acute lymphoblastic leukemia treatment.
Exploring how telomere length predicts survival in chronic lymphocytic leukemia (CLL) better than conventional tools, with insights into epigenetic programming and clinical applications.